1. Alemtuzumab mediates the CD39+ T‐regulatory cell response via CD23+ macrophages. Issue 5 (10th February 2021) Authors: Remez, Lital; Ganelin‐Cohen, Esther; Safina, Dina; Hellmann, Mark A; Lotan, Itay; Bosak, Noam; Buxbaum, Chen; Vaknin, Adi; Shifrin, Alla; Rozenberg, Ayal Journal: Immunology and cell biology Issue: Volume 99:Issue 5(2021) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗